Source: Virtual Congress 2021 – Future advances in respiratory physiology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Cherniak (Moscow, Russian Federation), M. Makarova (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation). Pulmonary function in patients with sporadic lymphangioleiomyomatosis.. 2507

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016 Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients}, Source: Eur Respir J 2012; 40: 630-640 Year: 2012 Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Pulmonary function in patients with acromegaly Source: Eur Respir J 2006; 28: Suppl. 50, 863s Year: 2006 Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Vascular dysfunction in patients with pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007 Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007